These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 720319)

  • 1. Strategy for the assessment of neurobehavioral consequences of environmental factors.
    Tilson HA; Cabe PA
    Environ Health Perspect; 1978 Oct; 26():287-99. PubMed ID: 720319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for neurobehavioral toxicity: the need for and examples of validation of testing procedures.
    Tilson HA; Mitchell CL; Cabe PA
    Neurobehav Toxicol; 1979; 1 Suppl 1():137-48. PubMed ID: 233760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurobehavioral screening in rodents.
    Moser VC
    Curr Protoc Toxicol; 2001 May; Chapter 11():Unit11.2. PubMed ID: 20957639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral toxicology in risk assessment: problems and research needs.
    Mitchell CL; Tilson HA
    Crit Rev Toxicol; 1982 Oct; 10(4):265-74. PubMed ID: 6756792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential behavioral profiling of stimulant substances in the rat using the LABORAS™ system.
    Castagné V; Wolinsky T; Quinn L; Virley D
    Pharmacol Biochem Behav; 2012 Jun; 101(4):553-63. PubMed ID: 22425596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobehavioral methods used in neurotoxicology.
    Tilson HA
    NIDA Res Monogr; 1993; 136():1-30; discussion 31-3. PubMed ID: 8289908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral indices of neurotoxicity.
    Tilson HA
    Toxicol Pathol; 1990; 18(1 Pt 2):96-104. PubMed ID: 2195643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative sensitivity of neurobehavioral tests for chemical screening.
    Moser VC; MacPhail RC
    Neurotoxicology; 1990; 11(2):335-44. PubMed ID: 2234549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobehavioral screening in rats: validation study.
    Alder S; Candrian R; Elsner J; Zbinden G
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):279-89. PubMed ID: 3724302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurobehavioral toxicity of acrylamide and IDPN (3,3'-iminodipropionitrile) in rats by 28-day oral administration--problems encountered in collaborative study and a commentary on conducting neurobehavioral testing].
    Okazaki S; Takashima H; Yamaguchi M; Hamamura M; Yamashita K; Okada M; Sunaga M; Tanaka R; Sato S; Umano T; Tsuji R; Yosioka T; Fujii T
    J Toxicol Sci; 2003 May; 28 Suppl 1():1-14. PubMed ID: 12822443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A promising indicator of neurobehavioral toxicity using the nematode Caenorhabditis elegans and computer tracking.
    Williams PL; Dusenbery DB
    Toxicol Ind Health; 1990; 6(3-4):425-40. PubMed ID: 2237928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the choice of subject populations for research in neurobehavioral toxicology.
    Donovick PJ; Horowitz GP
    J Toxicol Environ Health; 1982 Jul; 10(1):1-9. PubMed ID: 7131581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk assessment strategies for neuroprotective agents.
    Slikker W; Gaylor DW
    Ann N Y Acad Sci; 1995 Sep; 765():198-208; discussion 209. PubMed ID: 7486606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation and evolving science: neurobehavioral toxicology.
    Buckholtz NS; Panem S
    Neurobehav Toxicol Teratol; 1986; 8(1):89-96. PubMed ID: 3703099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for the prevention of environmental neurotoxic illness.
    Landrigan PJ; Graham DG; Thomas RD
    Environ Res; 1993 Apr; 61(1):157-63. PubMed ID: 8472670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction and replacement of laboratory animals in toxicological testing and research. Interim report 1984-1987.
    Zbinden G
    Biomed Environ Sci; 1988 Jun; 1(1):90-100. PubMed ID: 3077263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abuse liability assessment in preclinical drug development: predictivity of a translational approach for abuse liability testing using methylphenidate in four standardized preclinical study models.
    Teuns GB; Geys HM; Geuens SM; Stinissen P; Meert TF
    J Pharmacol Toxicol Methods; 2014; 70(3):295-309. PubMed ID: 24632211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity of misonidazole in rats following intravenous administration.
    Graziano MJ; Henck JW; Meierhenry EF; Gough AW
    Pharmacol Res; 1996 Jun; 33(6):307-18. PubMed ID: 8971952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of neurotoxicity potential in rats: the functional observational battery.
    Boucard A; Bétat AM; Forster R; Simonnard A; Froget G
    Curr Protoc Pharmacol; 2010 Dec; Chapter 10():Unit 10.12. PubMed ID: 21935896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biomarkers of neurotoxic effects induced by environmental chemicals].
    Indulski JA; Lutz W
    Med Pr; 1996; 47(4):383-91. PubMed ID: 8847985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.